Few new OTC drugs as South Korea focuses on specialty drugs

04/17/2013 | Yonhap News Agency (South Korea)

South Korean drugmakers' focus has shifted from over-the-counter drugs since the government mandated that OTC and prescription medicines be separated in 2000, according to the Korea Pharmaceutical Manufacturers Association. Of the 68 OTC drugs with sales volumes more than $4.45 million, only two have been introduced since 2000. Drugmakers are instead focusing their attention on developing and marketing specialized drugs, due in part to a cultural preference for prescription medications and the high cost of advertising OTC drugs.

View Full Article in:

Yonhap News Agency (South Korea)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN